Associated symptoms in the ten days before diagnosis of Kawasaki disease - PubMed (original) (raw)

Multicenter Study

. 2009 Apr;154(4):592-595.e2.

doi: 10.1016/j.jpeds.2008.10.006. Epub 2008 Nov 28.

Minmin Lu, L LuAnn Minich, Andrew M Atz, Gloria L Klein, Rosalind Korsin, Linda Lambert, Jennifer S Li, Wilbert Mason, Elizabeth Radojewski, Victoria L Vetter, Jane W Newburger; Pediatric Heart Network Investigators

Collaborators, Affiliations

Multicenter Study

Associated symptoms in the ten days before diagnosis of Kawasaki disease

Annette L Baker et al. J Pediatr. 2009 Apr.

Abstract

Objective: To describe common associated symptoms within the 10 days before diagnosis in subjects enrolled in the Pediatric Heart Network's trial of steroid therapy in Kawasaki disease (KD).

Study design: Patients with acute KD were enrolled between days 4 and 10 of illness at 8 centers between 2002 and 2004. We defined common associated symptoms as those occurring in >or=10% of patients. Principal clinical criteria for KD were not included in this analysis.

Results: Among 198 patients, irritability was reported in 98 (50%), vomiting in 88 (44%), decreased food/fluid intake in 73 (37%), cough in 55 (28%), diarrhea in 52 (26%), rhinorrhea in 37 (19%), weakness in 37 (19%), abdominal pain in 35 (18%), and joint pain (arthralgia or arthritis) in 29 (15%). One or more gastrointestinal symptom (vomiting, diarrhea, or abdominal pain) was present in 120 patients (61%) and 69 patients (35%) had >or= 1 respiratory symptom (rhinorrhea or cough).

Conclusions: Nonspecific symptoms occur commonly in children with KD. To reduce delays in diagnosis, clinicians should be educated that such symptoms may comprise a significant component in the chief complaint.

Trial registration: ClinicalTrials.gov NCT00132080.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation. 2004 Oct 26;110(17):2747–71. - PubMed
    1. Kawasaki T. Acute febrile mucocutaneous lymph node syndrome: Clinical observations of 50 cases. Japan J Allergology. 1967;16:178.
    1. Taubert KA, Rowley AH, Shulman ST. Nationwide survey of Kawasaki disease and acute rheumatic fever. J Pediatr. 1991;119:279–82. - PubMed
    1. Kato H, Sugimura T, Akagi T, Sato N, Hashino K, Maeno Y, et al. Long-term consequences of Kawasaki disease: a 10- to 21-year follow-up study of 594 patients. Circulation. 1996;94:1379–85. - PubMed
    1. Newburger JW, Takahasha M, Burns JC, Beiser AS, Duffy CE, Glode MP, et al. The treatment of Kawsaki syndrome with intravenous gamma gobulin. N Engl J Med. 1986;315:341–7. - PubMed

Publication types

MeSH terms

Grants and funding

LinkOut - more resources